Tanzania Prime Minister Kassim Majaliwa commended the Walter Reed Program-Tanzania (WRP-T) medication-assisted treatment (MAT) initiative to help people who use or injects. The MAT program follows harm reduction strategies, providing clients with medications in combination with counseling and behavioral therapies while also fighting HIV, TB and hepatitis B and C.
A Nigeria-U.S. collaboration has launched to develop Nigeria’s first-ever Malaria Slide Bank with funding from the U.S. President’s Malaria Initiative (PMI). This resource provides standard, validated slide sets for use in malaria trainings and in healthcare facilities.
In early 2021, as COVID-19 pandemic lockdowns and restrictions disrupted public life around the globe, MHRP faced the challenge of safely and ethically enrolling more than 100 participants in a new HIV vaccine adjuvant study in Kericho, Kenya.
MHRP and collaborators at two sites in Thailand are participating in the MAGI study, a NIAID-sponsored Phase 2 trial of a meningococcal Group B vaccine, Bexsero, in preventing gonococcal infection.
In 2021, MHRP, along with the Armed Forces Research Institute for Medical Sciences (AFRIMS) and the Department of Defense HIV/AIDS Prevention Program (DHAPP), received PEPFAR funding to develop a military-military partnership in the Philippines.
